Jorgen F Hansen

Title: The Innovations of Jorgen F Hansen: Revolutionizing Hemophilia Treatments

Introduction

Jorgen F Hansen is a prominent inventor based in Rodovre, Denmark, known for his significant contributions to medical innovations. With a remarkable portfolio of three patents, Hansen has focused on enhancing treatments for hemophilia through advanced processes involving human blood plasma.

Latest Patents

Hansen's latest inventions reflect his dedication to improving patient care. One of his key patents outlines a unique process for producing an antihemophilic factor (AHF) preparation from human blood plasma. This preparation is notable for its high solubility and long half-life, which ensures that patients can benefit from its effects. The method involves complete or partial thawing of deep-frozen human blood plasma through irradiation with electromagnetic waves, maintaining a temperature that does not exceed 10°C. The technique also includes centrifuging the thawed product to create a cryoprecipitate, which is further processed to isolate a concentrated solution suitable for patient self-injection.

Another significant patent developed by Hansen involves a process for recovering purified albumin from blood plasma using polyethylene glycol (PEG). This innovative approach enables the extraction of albumin in high purity by precipitating out impurities and thermocoagulating the resulting solution. The presence of caprylic acid enhances the isolation of purified albumin, showcasing Hansen's commitment to advancing treatment methodologies.

Career Highlights

As an inventor at Nordisk Insulinlaboratorium, Jorgen F Hansen has established himself as a key figure in medical research and innovation. His work has played a crucial role in enhancing treatment options for hemophilia patients, pushing the boundaries of what is possible in medical science. His contributions are not only advancing technology but are also saving lives.

Collaborations

Hansen has collaborated with renowned coworkers such as Mirella Ezban Rasmussen and Jorgen V Jensen, further enriching the innovative environment at Nordisk Insulinlaboratorium. Together, they have worked on groundbreaking projects that have the potential to transform patient treatment methodologies.

Conclusion

Jorgen F Hansen's dedication to innovation in the field of hemophilia treatment is evident through his patents and collaborative efforts. His work not only addresses existing challenges in patient care but also sets the stage for future advancements in medical science. As he continues to innovate, the impact of his contributions will resonate in the lives of many patients worldwide.